ms

Despite fraud charges and adverse publicity over bonus payments, Goldman Sachs has reclaimed its position as top global mergers and acquisitions advisor for the first half of 2010.

A marijuana-based prescription drug for multiple sclerosis, Sativex, hit U.K. pharmacies Monday after winning regulator approval Friday. In light of the new approval, are arguments against medical marijuana half-baked?

Federal prosecutors are looking into whether banks misled investors about their roles in mortgage-bond deals. Targeted banks include Citi, JPMorgan Chase, and UBS. At the same time, New York's Attorney General is launching a separate probe of whether some banks misled ratings agencies.

Morgan Stanley weathers investigations into sales of securities, joining Goldman Sachs on the list of Wall Street firms scrutinized by the SEC.

There is still no cure for the chronic disease multiple sclerosis, but separate late-stage studies on two different experimental drugs show them both to be effective at slowing it down. If approved by the FDA, the pills will be the first oral treatments available for the disease.

When JPMorgan Chase CEO Jamie Dimon and Bank of American (BAC) head Brian Moynihan flew today via corporate aircraft to Washington, D.C., to testify before a Congressional panel investigating the financial crisis, their mode of transport raised some eyebrows. But the furor over corporate jets, which are often the most efficient way to transport executives, distracts from the larger issues.

Sitting on a corporate board of directors has always been great work if you can get it, especially if it's with a company that's generous with board member compensation. These days, directors are feeling the heat to get some real work done.

Morgan Stanley (MS) CEO John Mack just loves regulators -- can't get enough of them. Speaking Wednesday at a conference sponsored by Bloomberg News and Vanity Fair, Mack seemed to wish more regulators were camped out in his New York-based firm, watching its every move. He'd better hope that the...

Large U.S. banks have raised money to improve their capital position this year, in some cases because the government required them to do so. Bank analysts have worried that a wave of write-downs on commercial real estate and credit card debt might require some big financial firms to go back to the...

Did Goldman Sachs Group (GS) Chief Executive Lloyd Blankfein invoke the lord's name in vain when he said Wall Street's most successful bank was doing "God's work?" Experts are divided. "The question of whether the CEO of Goldman Sachs is doing God's work is at one level a very complex one," says...